Today’s Research Reports on Trending Tickers: Keryx Biopharmaceuticals and Alder BioPharmaceuticals
U.S. markets closed at record highs Friday, posting weekly gains, on investor optimism over the current earnings season. The Dow Jones Industrial Average jumped 0.89 percent to close at 25,803.19, up 2.0 percent for the week, while the S&P 500 Index gained 0.67 percent to close at 2,786.24, up 1.6 percent for the week. 8 out of the 11 sectors in the S&P 500 closed in the green. The Nasdaq Composite Index hiked 0.68 percent to close at 7,261.06, ended 1.75 percent over the week.
“The economy is looking good, numbers look good, and companies are making money. This quarter may be a little messy because of the tax bill, but there’s so much optimism, so much enthusiasm about earnings,” said Michael Matousek, head trader at U.S. Global Investors. “Things are really starting to take off, and the only thing that makes it scary is the idea that we may be culminating to a top in the market.”
RDI Initiates Coverage on:
Keryx Biopharmaceuticals, Inc.
Alder BioPharmaceuticals, Inc.
Keryx Biopharmaceuticals stock moved 1.27% lower Friday, to close the day at $4.68. The stock recorded a trading volume of 822,128 shares, which was below its three months average volume of 1,986,512 shares. In the last year, Keryx Biopharmaceuticals shares have traded in a range of 4.33 – 8.38. The stock is currently trading 44.15% below its 52 week high. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $4.65 is below its 200-day moving average of $6.26. Shares of Keryx Biopharmaceuticals have gained roughly 2.18 percent in the past month and are up 0.65 percent year-to-date.
Access RDI’s Keryx Biopharmaceuticals, Inc. Research Report at:
On Friday, shares of Alder BioPharmaceuticals recorded a trading volume of 1,437,382 shares, which was above the three months average volume of 1,092,358 shares. The stock ended the day 0.28% lower at 17.85. The share price has gained 107.56% from its 52 week low with a 52 week trading range of 8.60 – 25.45.The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $12.10 is greater than its 200-day moving average of $11.11. Shares of Alder BioPharmaceuticals have gained roughly 66.82 percent in the past month and are up 55.9 percent year-to-date.
Access RDI’s Alder BioPharmaceuticals, Inc. Research Report at:
Our Actionable Research on Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) and Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.